Back to Search Start Over

Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients.

Authors :
Rico-Caballero V
Fernández M
Hurtado JC
Marcos MA
Cardozo C
Albiach L
Agüero D
Ambrosioni J
Bodro M
Chumbita M
De la Mora L
Garcia-Pouton N
Gonzalez-Cordón A
Dueñas G
Hernandez-Meneses M
Inciarte A
Laguno M
Leal L
Macaya I
Martínez MJ
Cuesta G
Meira F
Morata L
Puerta-Alcalde P
Rojas J
Torres B
Castro P
Muñoz J
Mensa J
Martínez JA
Sanjuan G
Vila J
García F
Garcia-Vidal C
Soriano A
Source :
Infection [Infection] 2022 Oct; Vol. 50 (5), pp. 1321-1328. Date of Electronic Publication: 2022 May 13.
Publication Year :
2022

Abstract

Purpose: Assess the impact of viral load estimated by cycle threshold (Ct) of reverse transcription real time-polymerase chain reaction (rRT-PCR) and the days from symptoms onset on mortality in hospitalized patients with COVID19.<br />Methods: Retrospective observational study of 782 patients with a positive rRT-PCR from a nasopharyngeal swab was performed within the first 24 h from admission. Demographic data, clinical manifestations and laboratory parameters were collected. Uni- and multivariate analyses were performed to identify factors associated with mortality at 60 days.<br />Results: Ct was divided into three groups and the mortality rate decreased from 27.3 to 20.7% and 9.8% for Ct values of ≤ 20, 21-25 and > 25, respectively (P = 0.0001). The multivariate analysis identified as predictors of mortality, a Ct value < 20 (OR 3.13, CI 95% 1.38-7.10), between 21-25 (OR 2.47, CI 95% 1.32-4.64) with respect to a Ct value > 25. Days from symptoms onset is a variable associated with mortality as well (DSOA) ≤ 6 (OR 1.86, CI 95% 1.00-3.46), among other factors. Patients requiring hospital admission within 6 DSOA with a Ct value ≤ 25 had the highest mortality rate (28%).<br />Conclusions: The inclusion of Ct values and DSOA in the characterization of study populations could be a useful tool to evaluate the efficacy of antivirals.<br /> (© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.)

Details

Language :
English
ISSN :
1439-0973
Volume :
50
Issue :
5
Database :
MEDLINE
Journal :
Infection
Publication Type :
Academic Journal
Accession number :
35562568
Full Text :
https://doi.org/10.1007/s15010-022-01833-8